Quick Takeaways
- 3i, LP filed SCHEDULE 13G/A for Valion Bio, Inc. Common Stock, par value $0.0001 per share (TIVC).
- Disclosed ownership: 9.9%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"3i, LP disclosed 9.9% ownership in Valion Bio, Inc. Common Stock, par value $0.0001 per share (TIVC) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 3i, LP | 9.9% | 307,526 | 0 | 307,526 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP | |
| Tumim Stone Capital LLC | 6.5% | 200,418 | 0 | 200,418 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow, Manager of 3i Management LLC, Manager of Tumim Stone Capital LLC | |
| 3i Management LLC | 9.9% | 307,526 | 0 | 307,526 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow, Manager | |
| Maier Joshua Tarlow | 9.9% | 307,526 | 0 | 307,526 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow |